129 results on '"Minai, Omar A."'
Search Results
2. Perioperative Management of the Patient with Pulmonary Hypertension
3. Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension
4. The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study
5. Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinil
6. Six-Minute Walk Test as a Predictor of Diagnosis, Disease Severity, and Clinical Outcomes in Scleroderma-Associated Pulmonary Hypertension: The DIBOSA Study
7. Rationale and study design of MOTION: A phase 4, prospective, single-arm, open-label study to measure outcomes in patients with pulmonary arterial hypertension not on active treatment
8. Scoring System for Screening of Pulmonary Hypertension in Scleroderma: The Dibosa Study
9. Effect of Age on Phenotype and Outcomes in Pulmonary Arterial Hypertension Trials
10. Abstract 14254: Right Ventricular Reverse Remodeling and Improved Systolic Function After Upfront Combination Therapy With Ambrisentan and Tadalafil in the Treatment of Scleroderma-Associated Pulmonary Arterial Hypertension
11. Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension
12. Measuring Outcomes in Patients With Pulmonary Arterial Hypertension (PAH) Not on Active Treatment (MOTION): A Study of the Effects of Riociguat on Patient-Reported Outcomes and an Exploration of Telemetric Technology in PAH
13. Upfront combination therapy in the treatment of scleroderma-associated pulmonary arterial hypertension: Results of an open label trial
14. Heart Rate Recovery is an Important Predictor of Outcomes in Patients with Connective Tissue Disease–Associated Pulmonary Hypertension
15. Outcomes of β-blocker use in pulmonary arterial hypertension: a propensity-matched analysis
16. Association of impaired heart rate recovery with cardiopulmonary complications after lung cancer resection surgery
17. Effect of Long-term Oral Anticoagulation in Pulmonary Arterial Hypertension (PAH)
18. Short-term and Long-term Outcomes in Patients With Scleroderma and IPAH Undergoing Lung Transplant
19. Impaired Functional Capacity Predicts Mortality in Patients with Obstructive Sleep Apnea
20. Heart rate slopes during 6-min walk test in pulmonary arterial hypertension, other lung diseases, and healthy controls
21. Presence and Outcomes of Kidney Disease in Patients with Pulmonary Hypertension
22. Clinical characteristics and prediction of pulmonary hypertension in severe emphysema
23. Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: 2014 updates
24. Electrocardiography at Diagnosis and Close to the Time of Death in Pulmonary Arterial Hypertension
25. Clinical Characterization and Survival of Patients with Borderline Elevation in Pulmonary Artery Pressure
26. Outcomes of Beta Blocker Use in Pulmonary Arterial Hypertension
27. Predictors of Outcome in Portopulmonary Hypertension
28. Value of Impedance Cardiography during 6-Minute Walk Test in Pulmonary Hypertension
29. Causes and Circumstances of Death in Pulmonary Arterial Hypertension
30. Perioperative Risk and Management in Patients With Pulmonary Hypertension
31. Long-Term Continuous Positive Airway Pressure Therapy Normalizes High Exhaled Nitric Oxide Levels in Obstructive Sleep Apnea
32. HEART RATE RECOVERY PREDICTS CLINICAL WORSENING IN PATIENTS WITH CONGENITAL HEART DISEASE ASSOCIATED PULMONARY ARTERIAL HYPERTENSION
33. OUTCOME OF LUNG DISEASE-RELATED PULMONARY HYPERTENSION AND IMPACT OF PULMONARY VASOREACTIVITY
34. Updating Clinical Endpoint Definitions
35. Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis
36. Heart Rate Recovery as a Predictor of Clinical Worsening in Patients With Pulmonary Arterial Hypertension Associated With Connective Tissue Diseases
37. Electrocardiographic Findings Before Death in Pulmonary Hypertension
38. Physician Monitoring of Pulmonary Arterial Hypertension Subjects: Results From a Large U.S. Health Insurance Claims Database
39. The Correlation Between Heart Rate Recovery After 6-Minute Walk Test and FEV 1 and Exercise Performance in Patient With Chronic Obstructive Airway Diseas
40. Effect of Obesity on B-Type Natriuretic Peptide Levels in Patients With Pulmonary Arterial Hypertension
41. Prevalence and Significance of Decreased Bone Density in Pulmonary Arterial Hypertension
42. Heart Rate Recovery After Six-Minute Walk Test Predicts Survival And Hospitalization In PAH
43. Patient Reported Quality Of Life After Rapid Transition From IV Epoprostenol To IV Treprostinil At Multiple Centers
44. Coenzyme Q Affects Cardiac Function And Erythropoiesis In Pulmonary Arterial Hypertension
45. Abnormal Platelet Aggregation In Idiopathic Pulmonary Arterial Hypertension: Role Of Nitric Oxide
46. Comparison of Baseline Predictors of Prognosis in Pulmonary Arterial Hypertension in Patients Surviving ≤2 Years and Those Surviving ≥5 Years After Baseline Right-Sided Cardiac Catheterization
47. Abnormal platelet aggregation in idiopathic pulmonary arterial hypertension: role of nitric oxide
48. Heart Rate Recovery Predicts Clinical Worsening in Patients with Pulmonary Arterial Hypertension
49. Pulmonary hypertension before first and second lung transplantation
50. Lung deflation and oxygen pulse in COPD: Results from the NETT randomized trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.